Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Germany's STIKO to recommend J&J COVID vaccine for over-60s - Spiegel

Fri, 07th May 2021 11:58

BERLIN, May 7 (Reuters) - Germany's vaccine committee, known
as STIKO, plans to recommend Johnson & Johnson's
COVID-19 vaccine only for people over the age of 60, German
magazine Der Spiegel reported on Friday, citing no sources.

Europe's drug regulator backed J&J's vaccine last month
after examining cases of a rare blood clotting issue in U.S.
adults who received a dose. But it left it up to the European
Union's member states to decide how to use it.

STIKO has also recommended AstraZeneca's COVID-19
shot to those aged 60 and above due to the risk of rare blood
clots.
(Reporting by Maria Sheahan
Editing by Riham Alkousaa)

Related Shares

More News
Today 07:46

AstraZeneca completes collaboration and investment deal with Cellectis

(Alliance News) - AstraZeneca PLC on Monday said it has completed an equity investment in clinical-stage biotechnology company Cellectis, first announ...

3 May 2024 12:17

CORRECT: Angle shares up on assay development deal with AstraZeneca

(Correcting company name in headline)

3 May 2024 11:50

Angle shares up on assay development deal with AstraZenaca

(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsort...

3 May 2024 07:50

LONDON BRIEFING: InterContinental Hotels makes first-quarter progress

(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out...

2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for pr...

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.